Teladoc Health (NYSE:TDOC) Now Covered by Analysts at The Goldman Sachs Group

The Goldman Sachs Group initiated coverage on shares of Teladoc Health (NYSE:TDOC) in a research note issued to investors on Friday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $14.00 price objective on the health services provider’s stock.

Several other equities analysts have also recently issued reports on the stock. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research note on Friday, November 1st. DA Davidson dropped their price target on shares of Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a research note on Thursday, August 1st. Royal Bank of Canada raised their price objective on shares of Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research report on Wednesday, October 9th. Jefferies Financial Group boosted their target price on Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a research report on Tuesday, September 17th. Finally, TD Cowen reduced their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Fourteen analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $12.08.

Teladoc Health Stock Performance

Teladoc Health stock traded up $0.25 during midday trading on Friday, hitting $9.21. 11,492,153 shares of the company’s stock were exchanged, compared to its average volume of 5,534,646. The firm’s 50 day simple moving average is $8.89 and its 200 day simple moving average is $9.41. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $22.54. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of -1.59 and a beta of 0.90.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. Equities research analysts predict that Teladoc Health will post -1.19 EPS for the current year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, Director Thomas Mckinley acquired 4,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were acquired at an average price of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the acquisition, the director now directly owns 39,077 shares of the company’s stock, valued at $300,502.13. This trade represents a 11.40 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Mala Murthy sold 8,750 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $62,650.00. Following the completion of the transaction, the chief financial officer now owns 85,767 shares of the company’s stock, valued at $614,091.72. The trade was a 9.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,051 shares of company stock worth $143,565. 0.95% of the stock is owned by insiders.

Institutional Trading of Teladoc Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Signaturefd LLC raised its position in shares of Teladoc Health by 148.7% in the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after buying an additional 1,715 shares during the period. International Assets Investment Management LLC purchased a new position in shares of Teladoc Health in the 2nd quarter worth about $29,000. SageView Advisory Group LLC acquired a new position in shares of Teladoc Health in the 1st quarter valued at about $48,000. Covestor Ltd grew its holdings in shares of Teladoc Health by 58.1% during the 1st quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock worth $57,000 after purchasing an additional 1,403 shares during the period. Finally, Blue Trust Inc. increased its position in Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after purchasing an additional 1,854 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.